263 related articles for article (PubMed ID: 26414664)
1. Studying a Drug-like, RNA-Focused Small Molecule Library Identifies Compounds That Inhibit RNA Toxicity in Myotonic Dystrophy.
Rzuczek SG; Southern MR; Disney MD
ACS Chem Biol; 2015 Dec; 10(12):2706-15. PubMed ID: 26414664
[TBL] [Abstract][Full Text] [Related]
2. Development of pharmacophore models for small molecules targeting RNA: Application to the RNA repeat expansion in myotonic dystrophy type 1.
Angelbello AJ; González ÀL; Rzuczek SG; Disney MD
Bioorg Med Chem Lett; 2016 Dec; 26(23):5792-5796. PubMed ID: 27839685
[TBL] [Abstract][Full Text] [Related]
3. Rationally designed small molecules that target both the DNA and RNA causing myotonic dystrophy type 1.
Nguyen L; Luu LM; Peng S; Serrano JF; Chan HY; Zimmerman SC
J Am Chem Soc; 2015 Nov; 137(44):14180-9. PubMed ID: 26473464
[TBL] [Abstract][Full Text] [Related]
4. Affinity capillary electrophoresis for identification of active drug candidates in myotonic dystrophy type 1.
Neaga IO; Hambye S; Bodoki E; Palmieri C; Ansseau E; Belayew A; Oprean R; Blankert B
Anal Bioanal Chem; 2018 Jul; 410(18):4495-4507. PubMed ID: 29736701
[TBL] [Abstract][Full Text] [Related]
5. Features of modularly assembled compounds that impart bioactivity against an RNA target.
Rzuczek SG; Gao Y; Tang ZZ; Thornton CA; Kodadek T; Disney MD
ACS Chem Biol; 2013 Oct; 8(10):2312-21. PubMed ID: 24032410
[TBL] [Abstract][Full Text] [Related]
6. A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.
Wagner-Griffin S; Abe M; Benhamou RI; Angelbello AJ; Vishnu K; Chen JL; Childs-Disney JL; Disney MD
J Med Chem; 2021 Jun; 64(12):8474-8485. PubMed ID: 34101465
[TBL] [Abstract][Full Text] [Related]
7. Precise small-molecule recognition of a toxic CUG RNA repeat expansion.
Rzuczek SG; Colgan LA; Nakai Y; Cameron MD; Furling D; Yasuda R; Disney MD
Nat Chem Biol; 2017 Feb; 13(2):188-193. PubMed ID: 27941760
[TBL] [Abstract][Full Text] [Related]
8. Rational design of chemical genetic probes of RNA function and lead therapeutics targeting repeating transcripts.
Disney MD
Drug Discov Today; 2013 Dec; 18(23-24):1228-36. PubMed ID: 23939337
[TBL] [Abstract][Full Text] [Related]
9. A toxic RNA catalyzes the in cellulo synthesis of its own inhibitor.
Rzuczek SG; Park H; Disney MD
Angew Chem Int Ed Engl; 2014 Oct; 53(41):10956-9. PubMed ID: 25164984
[TBL] [Abstract][Full Text] [Related]
10. Rational and modular design of potent ligands targeting the RNA that causes myotonic dystrophy 2.
Lee MM; Pushechnikov A; Disney MD
ACS Chem Biol; 2009 May; 4(5):345-55. PubMed ID: 19348464
[TBL] [Abstract][Full Text] [Related]
11. Rational Design of Small Molecules Targeting Oncogenic Noncoding RNAs from Sequence.
Disney MD; Angelbello AJ
Acc Chem Res; 2016 Dec; 49(12):2698-2704. PubMed ID: 27993012
[TBL] [Abstract][Full Text] [Related]
12. Comparison of small molecules and oligonucleotides that target a toxic, non-coding RNA.
Costales MG; Rzuczek SG; Disney MD
Bioorg Med Chem Lett; 2016 Jun; 26(11):2605-9. PubMed ID: 27117425
[TBL] [Abstract][Full Text] [Related]
13. Chemical correction of pre-mRNA splicing defects associated with sequestration of muscleblind-like 1 protein by expanded r(CAG)-containing transcripts.
Kumar A; Parkesh R; Sznajder LJ; Childs-Disney JL; Sobczak K; Disney MD
ACS Chem Biol; 2012 Mar; 7(3):496-505. PubMed ID: 22252896
[TBL] [Abstract][Full Text] [Related]
14. Molecular therapy in myotonic dystrophy: focus on RNA gain-of-function.
Mulders SA; van Engelen BG; Wieringa B; Wansink DG
Hum Mol Genet; 2010 Apr; 19(R1):R90-7. PubMed ID: 20406734
[TBL] [Abstract][Full Text] [Related]
15. Small molecule alteration of RNA sequence in cells and animals.
Guan L; Luo Y; Ja WW; Disney MD
Bioorg Med Chem Lett; 2018 Sep; 28(16):2794-2796. PubMed ID: 29079470
[TBL] [Abstract][Full Text] [Related]
16. Speeding drug discovery targeting RNAs: An iterative "RNA selection-compounds screening cycle" for exploring RNA-small molecule pairs.
Furuzono T; Murata A; Okuda S; Mizutani K; Adachi T; Nakatani K
Bioorg Med Chem; 2021 Apr; 36():116070. PubMed ID: 33773376
[TBL] [Abstract][Full Text] [Related]
17. Design of a bioactive small molecule that targets r(AUUCU) repeats in spinocerebellar ataxia 10.
Yang WY; Gao R; Southern M; Sarkar PS; Disney MD
Nat Commun; 2016 Jun; 7():11647. PubMed ID: 27248057
[TBL] [Abstract][Full Text] [Related]
18. Small-Molecule Library Subset Screening as an Aid for Accelerating Lead Identification.
Beresini MH; Liu Y; Dawes TD; Clark KR; Orren L; Schmidt S; Turincio R; Jones SW; Rodriguez RA; Thana P; Hascall D; Gross DP; Skelton NJ
J Biomol Screen; 2014 Jun; 19(5):758-70. PubMed ID: 24518067
[TBL] [Abstract][Full Text] [Related]
19. Phenotype-driven chemical screening in zebrafish for compounds that inhibit collective cell migration identifies multiple pathways potentially involved in metastatic invasion.
Gallardo VE; Varshney GK; Lee M; Bupp S; Xu L; Shinn P; Crawford NP; Inglese J; Burgess SM
Dis Model Mech; 2015 Jun; 8(6):565-76. PubMed ID: 25810455
[TBL] [Abstract][Full Text] [Related]
20. Approaches to Validate and Manipulate RNA Targets with Small Molecules in Cells.
Childs-Disney JL; Disney MD
Annu Rev Pharmacol Toxicol; 2016; 56():123-40. PubMed ID: 26514201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
